Mertelsmann R - Search Results

1

Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.

Herrmann F, Mertelsmann R, Lindemann A, Ottmann OG, Seipelt G, Oster W, Hoelzer D, Ganser A. Herrmann F, et al. Among authors: mertelsmann r. Biotechnol Ther. 1991;2(3-4):299-311. Biotechnol Ther. 1991. PMID: 1845132 Clinical Trial.

2

Cytokines in the pathogenesis and management of non-Hodgkin's lymphomas.

Cicco NA, Lübbert M, Oster W, Lindemann A, Mertelsmann R. Cicco NA, et al. Among authors: mertelsmann r. Hematol Oncol Clin North Am. 1991 Oct;5(5):1053-66. Hematol Oncol Clin North Am. 1991. PMID: 1938755 Review.

3

Biologic effects of recombinant human interleukin-3 in vivo.

Lindemann A, Ganser A, Herrmann F, Frisch J, Seipelt G, Schulz G, Hoelzer D, Mertelsmann R. Lindemann A, et al. Among authors: mertelsmann r. J Clin Oncol. 1991 Dec;9(12):2120-7. doi: 10.1200/JCO.1991.9.12.2120. J Clin Oncol. 1991. PMID: 1960553 Clinical Trial.

4

Treatment of patients with anemia of malignancy with recombinant human erythropoietin.

Herrmann F, Oster W, Mertelsmann R. Herrmann F, et al. Among authors: mertelsmann r. Contrib Nephrol. 1991;88:238-45; discussion 246-7. doi: 10.1159/000419532. Contrib Nephrol. 1991. PMID: 2040185 Review. No abstract available.

5

Hemopoietins in clinical oncology.

Kanz L, Lindemann A, Oster W, Herrmann F, Mertelsmann R. Kanz L, et al. Among authors: mertelsmann r. Am J Clin Oncol. 1991;14 Suppl 1:S27-33. doi: 10.1097/00000421-199112001-00006. Am J Clin Oncol. 1991. PMID: 2048561 Review.

6

Clinical effects of recombinant human interleukin-3.

Ganser A, Lindemann A, Seipelt G, Ottmann OG, Herrmann F, Eder M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Among authors: mertelsmann r. Am J Clin Oncol. 1991;14 Suppl 1:S51-63. doi: 10.1097/00000421-199112001-00010. Am J Clin Oncol. 1991. PMID: 2048566 Review.

7

In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia.

Herrmann F, Lindemann A, Raghavachar A, Heimpel H, Mertelsmann R. Herrmann F, et al. Among authors: mertelsmann r. Leukemia. 1990 Oct;4(10):671-2. Leukemia. 1990. PMID: 2214870

8

Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administration.

Herrmann F, Ganser A, Lindemann A, Schulz G, Lübbert M, Hoelzer D, Mertelsmann R. Herrmann F, et al. Among authors: mertelsmann r. J Biol Response Mod. 1990 Oct;9(5):475-9. J Biol Response Mod. 1990. PMID: 2254759 Clinical Trial.

9

Hematopoietic growth factors in oncology.

Mertelsmann R, Lindemann A, Oster W, Gamm H, Kolbe K, Herrmann F. Mertelsmann R, et al. Cancer Detect Prev. 1990;14(6):613-6. Cancer Detect Prev. 1990. PMID: 2257558 Review.

10

Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure.

Ganser A, Lindemann A, Seipelt G, Ottmann OG, Herrmann F, Eder M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Among authors: mertelsmann r. Blood. 1990 Aug 15;76(4):666-76. Blood. 1990. PMID: 2383650 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters